scispace - formally typeset
L

Lindsey Wooliscroft

Researcher at Oregon Health & Science University

Publications -  15
Citations -  138

Lindsey Wooliscroft is an academic researcher from Oregon Health & Science University. The author has contributed to research in topics: Multiple sclerosis & Medicine. The author has an hindex of 5, co-authored 11 publications receiving 62 citations. Previous affiliations of Lindsey Wooliscroft include United States Department of Veterans Affairs & Allen Institute for Brain Science.

Papers
More filters
Journal ArticleDOI

COVID-19 vaccination willingness among people with multiple sclerosis

Xinran M Xiang, +5 more
TL;DR: In this article, the authors investigated the factors contributing to the willingness to receive COVID-19 vaccination in adults with multiple sclerosis (MS) and found that the vaccine willingness was positively associated with the risk of developing MS.
Journal ArticleDOI

Phase I randomized trial of liothyronine for remyelination in multiple sclerosis: A dose-ranging study with assessment of reliability of visual outcomes.

Lindsey Wooliscroft, +9 more
- 20 Feb 2020 - 
TL;DR: The results support that, despite small variations over one week, VEP with various check sizes and Sloan LCLA are reliable functional and clinical outcome measures that could be used in remyelination clinical trials in MS.
Journal ArticleDOI

Approaches to Remyelination Therapies in Multiple Sclerosis.

Lindsey Wooliscroft, +4 more
- 28 Jun 2019 - 
TL;DR: Current approaches to remyelination include blocking inhibitors of remyELination, improving the clearance of myelin debris, increasing the number of oligodendrocyte precursor cells (OPCs), and stimulating OPC differentiation.
Journal ArticleDOI

Using the Anterior Visual System to Assess Neuroprotection and Remyelination in Multiple Sclerosis Trials.

Elizabeth Silbermann, +3 more
- 19 Jun 2018 - 
TL;DR: This article provides a review of established and novel techniques to measure the anterior visual system in multiple sclerosis with a focus on the evidence to support their use as outcome measures in clinical trials focused on neuroprotection and remyelination therapies.
Journal ArticleDOI

Cross-sectional survey of complementary and alternative medicine used in Oregon and Southwest Washington to treat multiple sclerosis: A 17-Year update.

Elizabeth Silbermann, +11 more
- 07 Mar 2020 - 
TL;DR: Findings highlight the high and increasing prevalence of CAM use in pwMS and factors associated with CAM use, and underscore the importance of research to investigate safety and efficacy of these therapies.